Thiazolidinedione analogs for the treatment of NAFLD and metabolic diseases Grant US-11931345-B2 United States of America 19 Mar 2024
NOVEL COMPOUNDS, COMPOSITIONS AND THERAPEUTIC USES THEREOF Application WO-2024052690-A1 World Intellectual Property Organisation (WIPO) 14 Mar 2024
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Grant US-11786487-B2 United States of America 17 Oct 2023
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Grant US-11759440-B2 United States of America 19 Sep 2023
Metabolism resistant fenfluramine analogs and methods of using the same Grant US-11673852-B2 United States of America 13 Jun 2023
Fenfluramine compositions and methods of preparing the same Grant US-11634377-B2 United States of America 25 Apr 2023
Method of treating patients infected with severe acute respiratory syndrome coronavirus 2 … Grant US-11612574-B2 United States of America 28 Mar 2023
Compositions and methods for treating seizure-induced sudden death Grant US-11571397-B2 United States of America 07 Feb 2023
SYSTEM-BIOLOGY BASED PHARMACEUTICAL COMPOSITION COMPRISING A MIXTURE OF HERB EXTRACTS AS… Application WO-2022250542-A1 World Intellectual Property Organisation (WIPO) 01 Dec 2022
Ketogenic diet compatible fenfluramine formulation Grant US-11458111-B2 United States of America 04 Oct 2022
COMPOSITION FOR USE IN THE TREATMENT OF COVID-19 Application WO-2022195558-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022
ANTI VIRAL THERAPY Application WO-2022195296-A1 World Intellectual Property Organisation (WIPO) 22 Sep 2022
BENZO[C][2,6]NAPHTHYRIDINE DERIVATIVES, COMPOSITIONS AND THERAPEUTIC USES THEREOF Application WO-2022185041-A1 World Intellectual Property Organisation (WIPO) 09 Sep 2022
USE OF DIAZEPAM AS ONLY TOLERATED BENZODIAZEPINE RECEPTOR AGONIST IN COVID-19 PATIENTS Application WO-2022167685-A1 World Intellectual Property Organisation (WIPO) 11 Aug 2022
USE OF DIAZEPAM AS ONLY TOLERATED BENZODIAZEPINE RECEPTOR AGONIST IN COVID-19 PATIENTS Application EP-4039258-A1 European Patent Office 10 Aug 2022
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Grant US-11406606-B2 United States of America 09 Aug 2022
METHODS FOR MODULATING HOST CELL SURFACE INTERACTIONS WITH SARS-COV-2 Application WO-2022109441-A1 World Intellectual Property Organisation (WIPO) 27 May 2022
RNA INTERACTOME CAPTURING PROTOCOL AND ANTIVIRAL COMPOSITION DISCOVERED USING SAME Application WO-2022092995-A2 World Intellectual Property Organisation (WIPO) 05 May 2022
SYSTEMS FOR AND METHODS OF TREATMENT SELECTION Application WO-2022081920-A1 World Intellectual Property Organisation (WIPO) 21 Apr 2022
COMPOUNDS FOR TREATING VIRUS INFECTIONS Application WO-2022058533-A1 World Intellectual Property Organisation (WIPO) 24 Mar 2022
METHOD FOR PREDICTING THE SEVERITY OF THE PROGRESSION OF A COVID-19 INFECTION Application EP-3964588-A1 European Patent Office 09 Mar 2022
USE OF MAIT CELLS AS BIOMARKERS AND BIOTARGETS IN COVID-19 Application WO-2022043496-A2 World Intellectual Property Organisation (WIPO) 03 Mar 2022
METHOD OF TREATING PATIENTS INFECTED WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 … Application WO-2022013425-A1 World Intellectual Property Organisation (WIPO) 20 Jan 2022
USE OF MULTI-KINASE INHIBITORS TO TREAT RNA VIRUS INFECTIONS Application WO-2021252494-A1 World Intellectual Property Organisation (WIPO) 16 Dec 2021
MODULATORS OF PURINERGIC RECEPTORS AND RELATED IMMUNE CHECKPOINT FOR TREATING ACUTE… Application WO-2021245107-A2 World Intellectual Property Organisation (WIPO) 09 Dec 2021
TREATMENT OF VIRAL INFECTION, DISEASE OR DISORDER USING A SELECTIVE S1R AGONIST Application WO-2021224914-A1 World Intellectual Property Organisation (WIPO) 11 Nov 2021
Compounds that participate in cooperative binding and uses thereof Grant US-11059830-B2 United States of America 13 Jul 2021